Entity
Description
  • Value proposition

    Developing Tomorrow's Antibacterials

    Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio

    Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant

  • Original language

    Developing Tomorrow's Antibacterials

    Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio

  • Antabio

    Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

  • https://antabio.com/
Catalyst interactions
Catalyst TypeTweets Articles
Omnes
Omnes
Startup accelerator & VC, Financial Services
Omnes
Startup accelerator & VC, Financial Services
Not capitalistic
Not partnership
Event

5 Sep 2018


bioMérieux
bioMérieux
Biotechnology, Biotechnology Research
bioMérieux
Biotechnology, Biotechnology Research
Capitalistic
Partnership
Not event

10 Jan 2022

17 Oct 2023



Social network dynamics
Similar entities
BETA
Loading...
Loading...